TITLE

Safety and Efficacy of Intensive Insulin Therapy in Patients With Thermal Injury

AUTHOR(S)
Patel, Mallika P.; Weant, Kyle A.; Ritter, Britt A.; Cairns, Bruce A.
PUB. DATE
January 2009
SOURCE
Hospital Pharmacy;Jan2009, Vol. 44 Issue 1, p41
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: To evaluate the safety and efficacy of intensive insulin therapy (IIT) versus traditional corrective insulin management (CIM) for the treatment of hyperglycemia in adult patients with thermal injury who are under intensive care. Methods: Using a searchable pharmacy database, a retrospective, observational chart review was conducted of adult patients who were admitted to the surgical burn service intensive care unit (ICU) at the University of North Carolina Hospitals (LINCH) from January 2004 through December 2005 and who had received insulin therapy. Results: Seventy-one patients qualified for analysis. The average morning serum blood glucose value while patients were receiving IIT, defined as 80 to 110 mg/dL, was 107 mg/dL compared with 124 mg/dL while patients were receiving CIM (P < 0.001). Of morning serum blood glucose values taken, 49% were within the target range in patients receiving IIT compared with 34% in patients receiving CIM (P < 0.001). No significant differences were found between the 2 groups with regard to mortality, ICU stay, or hospital stay. More patients experienced hypoglycemia (blood glucose value less than 50 mg/dL) while receiving IIT compared with CIM (36.4% vs 31.3%; P = 0.732); however, none of the patients had symptomatic hypoglycemia. There was a significantly higher rate of hypoglycemia among nonsurvivors compared with survivors (66.7% vs 26.4%; P = 0.006). Conclusion: IIT lowers average morning blood glucose in the thermal injury population when compared with CIM. Differences in hypoglycemic events were observed in this review; however, none of the episodes were symptomatic. Although further study is needed, IIT appears to be a safe and effective method of controlling serum blood glucose values in this specialized population.
ACCESSION #
36266281

 

Related Articles

  • Adherence to the Standard Guidelines for Prescription of Antidiabetic Agents in Patients with Type 2 DM. Alhadidi, Qasim M.; Sahib, Ahmed S.; Jaffer, Ali M.; Ismael, Maha H.; Hassan, Ekhlas K.; Shareef, Saja M.; Shoesh, Asmaa M.; Dawood, Asia S. // Journal of Applied Pharmaceutical Science;Jul2012, Vol. 2 Issue 7, p1 

    Prescription of appropriate antihyperglycemic agent depending on the standard guidelines has an important role in controlling diabetes and improving patient health. The aim of the present prospective study is to follow-up the adherence of prescribers to the standard guidelines for the...

  • Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer. Heinemann, Lutz; Klappoth, W.; Rave, K.; Hompesch, B.; Linkeschowa, R.; Heise, T.; Heinemann, L // Diabetes Care;Sep2000, Vol. 23 Issue 9, p1343 

    Objective: To study the metabolic effect and the variability of the effect elicited by inhalation of 87.2 U insulin powder combined with an absorption enhancer. The metabolic effect was compared with that of 10.2 U regular insulin injected subcutaneously and of 5.5 U regular insulin...

  • Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Musi, Nicolas; Hirshman, Michael F.; Nygren, Jonas; Svanfeldt, Monika; Bavenholm, Peter; Rooyackers, Olav; Zhou, Gaochao; Williamson, Joanne M.; Ljunqvist, Olle; Efendic, Suad; Moller, David E.; Thorell, Anders; Goodyear, Laurie J. // Diabetes;Jul2002, Vol. 51 Issue 7, p2074 

    Metformin is an effective hypoglycemic drug that lowers blood glucose concentrations by decreasing hepatic glucose production and increasing glucose disposal in skeletal muscle; however, the molecular site of metformin action is not well understood. AMP-activated protein kinase (AMPK) activity...

  • IV Exenatide Has the Same Efficacy as Insulin in C ICU Patients, Without Inducing Hypoglycemia. Buckley, Rita // MD Conference Express;Aug2011, p10 

    The article reports on research which was conducted by Steven P. Marso of St. Luke’s Mid America Heart & Vascular Institute in Kansas City, Missouri, to determine the feasibility, efficacy, and safety of intravenous (IV) exenatide in hyperglycemic cardiac intensive care unit (CICU)...

  • Type 2 Diabetes: Updated Evidence Requires Updated Decision Making. SHAUGHNESSY, ALLEN F.; ERLICH, DEBORAH R.; SLAWSON, DAVID C. // American Family Physician;7/1/2015, Vol. 92 Issue 1, p22 

    The article comments on the paper "Management of blood glucose with noninsulin therapies in type 2 diabetes" by C. M. George and colleagues. Topics discussed include the small subset of patients who benefit from normalizing blood glucose levels, the tendency to over-treat hyperglycemia using...

  • Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Inzucchi, Silvio E.; Bergenstal, Richard M.; Buse, John B.; Diamant, Michaela; Ferrannini, Ele; Nauck, Michael; Peters, Anne L.; Tsapas, Apostolos; Wender, Richard; Matthews, David R. // Diabetes Care;Jan2015, Vol. 38 Issue 1, p140 

    The article offers information on hyperglycemia management for type 2 diabetes in the U.S. and updates for 2015. Topics include patient-centered approaches to management, the position statement from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes...

  • UPDATE ON TREATMENT OF TYPE 2 DIABETES MELLITUS. RUNGBY, JORGEN // Problemy Endokrinologii;2017 Supplement, p6 

    Type 2 diabetes is a heterogeneous disease and therefore it may be complicated to treat hyperglycaemia. Treatment is ideally based on pathophysiological knowledge about the causes of hyperglycaemia in the individual patient: «The right pill in the right mouth». The lecture will focus on...

  • Intensive versus Conventional Glucose Control in Critically Ill Patients.  // New England Journal of Medicine;3/26/2009, Vol. 360 Issue 13, p1283 

    The article presents a randomized, controlled trial that tested the effects of intensive versus conventional glucose control in critically ill patients. Adult medical and surgical patients expected to require treatment in the intensive care unit on three or more consecutive days were eligible...

  • Increasing Blood Glucose Variability Is a Precursor of Sepsis and Mortality in Burned Patients. Pisarchik, Alexander N.; Pochepen, Olga N.; Pisarchyk, Liudmila A.; Boccaletti, Stefano // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    High glycemic variability, rather than a mean glucose level, is an important factor associated with sepsis and hospital mortality in critically ill patients. In this retrospective study we analyze the blood glucose data of 172 nondiabetic patients 18-60 yrs old with second and third-degree burns...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics